80 FR 232 pgs. 75691-75692 - Bulk Manufacturer of Controlled Substances Application: Organix, Inc.
Type: NOTICEVolume: 80Number: 232Pages: 75691 - 75692
Pages: 75691, 75692Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2015-30554 Filed 12-2-15; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Organix, Inc.
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 1, 2016.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
[top] The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to
In accordance with 21 CFR 1301.33(a), this is notice that on September 7, 2015, Organix, Inc., 240 Salem Street, Woburn, Massachusetts 01801 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance | Schedule |
---|---|
Gamma Hydroxybutyric Acid (2010) | I |
Lysergic acid diethylamide (7315) | I |
Marihuana (7360) | I |
Tetrahydrocannabinols (7370) | I |
Psilocybin (7437) | I |
Psilocyn (7438) | I |
Heroin (9200) | I |
Morphine (9300) | II |
The company plans to manufacture reference standards for distribution to its research and forensics customers. In reference to drug codes 7360 (marihuana) and 7370 (THC) the company plans to manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.
Dated: November 27, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-30554 Filed 12-2-15; 8:45 am]
BILLING CODE 4410-09-P